Oslo University Hospital Rikshospitalet, Oslo (Norway)
Follow
Contributor content
Presentation
Il-6 inhibition in acute ST-elevation myocardial infarction
Presentation
The ASSAIL-MI trial: a Norwegian multicentre, randomised controlled trial designed to assess the effect of tocilizumab on ischaemia reperfusion injury in ST-elevation myocardial infarction
